Cureapp, Inc.

Cureapp, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

CureApp® is the leading digital health therapeutic medical device (software) company delivering an innovative solution called "Digital Therapeutics" to medical treatment fields based on robust scientific evidence.

Company Details

Employees
59
Founded
-
Address
12-5 Nihonbashi Kodenmacho Ys Building 4f, Chuo-Ku,tokyo 103-0001,japan
Phone
+81-3-6231-0183
Email
pr****@****eapp.jp
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
Chuo-ku, Tokyo
Looking for a particular Cureapp, Inc. employee's phone or email?

Cureapp, Inc. Questions

News

Japan Digital Health Market to hit US$ 51.42 Billion By 2033 | - openPR.com

Japan Digital Health Market to hit US$ 51.42 Billion By 2033 | openPR.com

CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New Form of App-based Prescription Treatment - The First Digital Therapeutic to Be Covered by Japan’s Public Healthcare Insurance System - Business Wire

CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New Form of App-based Prescription Treatment - The First Digital Therapeutic to Be Covered by Japan’s Public Healthcare Insurance System Business Wire

News Release: Toward Dissemination of Digital Therapeutics - The Worldfolio

News Release: Toward Dissemination of Digital Therapeutics The Worldfolio

CureApp gets funding treatment - - Global Venturing

CureApp gets funding treatment - Global Venturing

Japan clears CureApp's DTx app for hypertension - Mobi Health News

Japan clears CureApp's DTx app for hypertension Mobi Health News

Asia’s First Prescription “Digital Therapeutic” Approved in Japan; Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc. - Business Wire

Asia’s First Prescription “Digital Therapeutic” Approved in Japan; Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc. Business Wire

Cureapp shares results for hypertension digital therapeutic app, seeks regulatory approval and U.S. partner - BioWorld MedTech

Cureapp shares results for hypertension digital therapeutic app, seeks regulatory approval and U.S. partner BioWorld MedTech

Asia’s first therapeutic app gets approval in Japan - BioSpectrum Asia

Asia’s first therapeutic app gets approval in Japan BioSpectrum Asia

Japanese DTx app maker CureApp to receive $51M investment from Carlyle - Mobi Health News

Japanese DTx app maker CureApp to receive $51M investment from Carlyle Mobi Health News

CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1 - Business Wire

CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1 Business Wire

CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension - Business Wire

CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension Business Wire

Top Cureapp, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant